Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVERCOME: Enalapril and Carvedilol for Prevention of Chemotherapy-Induced Cardiotoxicity
NCT01110824Phase 3Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enalapril, carvedilol in left ventricular dysfunction, sponsored by Hospital Clínic de Barcelona. Started Apr 2008; status: completed.
02
Drugs
enalaprilcarvedilol
03
Conditions
left ventricular dysfunction
Beyond the preview
Go deeper on NCT01110824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110824.